Copyright Reports & Markets. All rights reserved.

Global Continuous Subcutaneous Insulin Infusion Devices Market Research Report 2021

Request for Sample of this report
Buy now

1 Continuous Subcutaneous Insulin Infusion Devices Market Overview

  • 1.1 Product Overview and Scope of Continuous Subcutaneous Insulin Infusion Devices
  • 1.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
    • 1.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Normal Pump
    • 1.2.3 Patch Pump
  • 1.3 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
    • 1.3.1 Continuous Subcutaneous Insulin Infusion Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Type I Diabetes
    • 1.3.3 Type II Diabetes
  • 1.4 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue 2016-2027
    • 1.4.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales 2016-2027
    • 1.4.3 Continuous Subcutaneous Insulin Infusion Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Continuous Subcutaneous Insulin Infusion Devices Market Competition by Manufacturers

  • 2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Continuous Subcutaneous Insulin Infusion Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation and Trends
    • 2.5.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players Market Share by Revenue
    • 2.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario by Region

  • 3.1 Global Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
    • 3.3.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
    • 3.3.2 North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
    • 3.4.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country
    • 3.4.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region
    • 3.5.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
    • 3.6.2 Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country
    • 3.7.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Continuous Subcutaneous Insulin Infusion Devices Historic Market Analysis by Type

  • 4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2016-2021)

5 Global Continuous Subcutaneous Insulin Infusion Devices Historic Market Analysis by Application

  • 5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Medtronic
    • 6.1.1 Medtronic Corporation Information
    • 6.1.2 Medtronic Description and Business Overview
    • 6.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Medtronic Product Portfolio
    • 6.1.5 Medtronic Recent Developments/Updates
  • 6.2 Roche
    • 6.2.1 Roche Corporation Information
    • 6.2.2 Roche Description and Business Overview
    • 6.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Roche Product Portfolio
    • 6.2.5 Roche Recent Developments/Updates
  • 6.3 Insulet Corp
    • 6.3.1 Insulet Corp Corporation Information
    • 6.3.2 Insulet Corp Description and Business Overview
    • 6.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Insulet Corp Product Portfolio
    • 6.3.5 Insulet Corp Recent Developments/Updates
  • 6.4 Tandem Diabetes care
    • 6.4.1 Tandem Diabetes care Corporation Information
    • 6.4.2 Tandem Diabetes care Description and Business Overview
    • 6.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Tandem Diabetes care Product Portfolio
    • 6.4.5 Tandem Diabetes care Recent Developments/Updates
  • 6.5 Valeritas
    • 6.5.1 Valeritas Corporation Information
    • 6.5.2 Valeritas Description and Business Overview
    • 6.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Valeritas Product Portfolio
    • 6.5.5 Valeritas Recent Developments/Updates
  • 6.6 SOOIL
    • 6.6.1 SOOIL Corporation Information
    • 6.6.2 SOOIL Description and Business Overview
    • 6.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 SOOIL Product Portfolio
    • 6.6.5 SOOIL Recent Developments/Updates
  • 6.7 Microport
    • 6.6.1 Microport Corporation Information
    • 6.6.2 Microport Description and Business Overview
    • 6.6.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Microport Product Portfolio
    • 6.7.5 Microport Recent Developments/Updates

7 Continuous Subcutaneous Insulin Infusion Devices Manufacturing Cost Analysis

  • 7.1 Continuous Subcutaneous Insulin Infusion Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
  • 7.4 Continuous Subcutaneous Insulin Infusion Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Continuous Subcutaneous Insulin Infusion Devices Distributors List
  • 8.3 Continuous Subcutaneous Insulin Infusion Devices Customers

9 Continuous Subcutaneous Insulin Infusion Devices Market Dynamics

  • 9.1 Continuous Subcutaneous Insulin Infusion Devices Industry Trends
  • 9.2 Continuous Subcutaneous Insulin Infusion Devices Growth Drivers
  • 9.3 Continuous Subcutaneous Insulin Infusion Devices Market Challenges
  • 9.4 Continuous Subcutaneous Insulin Infusion Devices Market Restraints

10 Global Market Forecast

  • 10.1 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Type (2022-2027)
  • 10.2 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Application (2022-2027)
  • 10.3 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Normal Pump
    Patch Pump

    Segment by Application
    Type I Diabetes
    Type II Diabetes

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Medtronic
    Roche
    Insulet Corp
    Tandem Diabetes care
    Valeritas
    SOOIL
    Microport

    Buy now